Get the Stockscreener App
178.86
0.67%
-1.21
Pre-market:
177.00
-1.86
-1.04%
Charles River Laboratories International Inc stock is traded at $178.86, with a volume of 670.70K.
It is down -0.67% in the last 24 hours and up +0.86% over the past month.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
See More
Previous Close:
$180.07
Open:
$178.46
24h Volume:
670.70K
Relative Volume:
0.70
Market Cap:
$8.80B
Revenue:
$4.06B
Net Income/Loss:
$413.08M
P/E Ratio:
22.33
EPS:
8.01
Net Cash Flow:
$560.48M
1W Performance:
-8.41%
1M Performance:
+0.86%
6M Performance:
+50.99%
1Y Performance:
-1.16%
1-Day Range:
$173.89
$178.94
1-Week Range:
$173.89
$193.47
52-Week Range:
$91.86
$230.02
Charles River Laboratories International Inc Stock (CRL) Company Profile
Name
Charles River Laboratories International Inc
Sector
Industry
Phone
781-222-6000
Address
251 BALLARDVALE ST, WILMINGTON, MA
Compare CRL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRL
Charles River Laboratories International Inc
|
178.86 | 8.86B | 4.06B | 413.08M | 560.48M | 8.01 |
|
TMO
Thermo Fisher Scientific Inc
|
564.88 | 213.17B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
214.06 | 152.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
722.94 | 50.36B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
144.69 | 41.49B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
213.88 | 36.86B | 15.90B | 1.28B | 2.21B | 7.2842 |
Charles River Laboratories International Inc Stock (CRL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-06-25 | Upgrade | William Blair | Mkt Perform → Outperform |
| Oct-02-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Sep-09-25 | Upgrade | Jefferies | Hold → Buy |
| Jul-09-25 | Upgrade | Citigroup | Neutral → Buy |
| May-23-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| May-14-25 | Upgrade | TD Cowen | Hold → Buy |
| May-08-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-21-25 | Downgrade | Goldman | Buy → Neutral |
| Mar-04-25 | Upgrade | Citigroup | Sell → Neutral |
| Mar-03-25 | Upgrade | Redburn Atlantic | Sell → Neutral |
| Jan-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-17-25 | Downgrade | UBS | Buy → Neutral |
| Nov-18-24 | Downgrade | CLSA | Hold → Underperform |
| Nov-07-24 | Upgrade | CLSA | Underperform → Hold |
| Oct-23-24 | Initiated | CLSA | Underperform |
| Oct-14-24 | Initiated | Redburn Atlantic | Sell |
| Oct-07-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-01-24 | Downgrade | Citigroup | Neutral → Sell |
| Aug-08-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-08-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jun-28-24 | Downgrade | Argus | Buy → Hold |
| Jun-07-24 | Initiated | Mizuho | Neutral |
| Jun-06-24 | Initiated | Goldman | Buy |
| Feb-15-24 | Downgrade | Guggenheim | Buy → Neutral |
| Sep-13-23 | Initiated | TD Cowen | Market Perform |
| Jul-10-23 | Downgrade | Citigroup | Buy → Neutral |
| Feb-23-23 | Upgrade | Guggenheim | Neutral → Buy |
| Jan-12-23 | Downgrade | Jefferies | Buy → Hold |
| Sep-30-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Aug-04-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-24-22 | Initiated | Guggenheim | Neutral |
| Apr-25-22 | Downgrade | Jefferies | Buy → Hold |
| Apr-07-22 | Initiated | Stephens | Overweight |
| Feb-17-22 | Reiterated | BofA Securities | Buy |
| Feb-17-22 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-22 | Reiterated | Deutsche Bank | Buy |
| Feb-17-22 | Reiterated | Morgan Stanley | Overweight |
| Feb-17-22 | Reiterated | UBS | Buy |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Sep-10-20 | Upgrade | Jefferies | Hold → Buy |
| Jul-01-20 | Upgrade | BofA Securities | Neutral → Buy |
| May-13-20 | Upgrade | UBS | Neutral → Buy |
| Apr-21-20 | Downgrade | Jefferies | Buy → Hold |
| Mar-27-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Mar-02-20 | Initiated | Deutsche Bank | Buy |
| Feb-18-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-10-20 | Upgrade | Goldman | Neutral → Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Oct-18-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-10-19 | Initiated | SVB Leerink | Outperform |
| Apr-30-19 | Resumed | Evercore ISI | Outperform |
| Dec-14-18 | Initiated | Deutsche Bank | Buy |
| Oct-09-18 | Initiated | UBS | Neutral |
| Aug-23-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-17-18 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jun-15-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| Feb-14-18 | Upgrade | SunTrust | Hold → Buy |
View All
Charles River Laboratories International Inc Stock (CRL) Latest News
Will Charles River Laboratories International Inc. stock maintain dividend yieldWeekly Trade Report & Low Drawdown Momentum Ideas - newser.com
Can Charles River Laboratories International Inc. stock deliver double digit returnsJuly 2025 Selloffs & Consistent Income Trade Ideas - newser.com
How strong is Charles River Laboratories International Inc. (RV6) stock earnings growth2025 Major Catalysts & Community Trade Idea Sharing - newser.com
Will Charles River Laboratories International Inc. (RV6) stock announce special dividendJuly 2025 PreEarnings & Verified Momentum Stock Watchlist - newser.com
What To Expect From Charles River Laboratories’s (CRL) Q3 Earnings - FinancialContent
What earnings revisions data tells us about Charles River Laboratories International Inc.Earnings Beat & High Conviction Buy Zone Picks - newser.com
Charles River Laboratories International Inc. stock chart pattern explainedMarket Volume Report & Technical Analysis for Trade Confirmation - newser.com
Signal strength of Charles River Laboratories International Inc. stock in tech scannersQuarterly Investment Review & Daily Stock Trend Reports - newser.com
Why hedge funds are buying Charles River Laboratories International Inc. stockJobs Report & Free Accurate Trade Setup Notifications - newser.com
Will Charles River Laboratories International Inc. stock maintain growth story2025 Technical Patterns & Weekly Return Optimization Plans - newser.com
Nicholas Company Inc. Cuts Stock Holdings in Charles River Laboratories International, Inc. $CRL - MarketBeat
How Charles River Laboratories International Inc. (RV6) stock valuation compares with sector2025 Market Outlook & High Conviction Buy Zone Alerts - newser.com
Will Charles River Laboratories International Inc. stock benefit from green energy trendsTrend Reversal & Stepwise Trade Execution Plans - newser.com
What macro factors could drive Charles River Laboratories International Inc. (RV6) stock higherJuly 2025 Final Week & Verified Technical Signals - newser.com
Will Charles River Laboratories International Inc. stock benefit from commodity pricesTrade Entry Summary & Fast Gain Stock Trading Tips - newser.com
Sector ETF performance correlation with Charles River Laboratories International Inc.M&A Rumor & Fast Exit Strategy with Risk Control - newser.com
What does recent volatility data suggest for Charles River Laboratories International Inc.July 2025 Spike Watch & Reliable Price Action Trade Plans - newser.com
Can Charles River Laboratories International Inc. (RV6) stock withstand sector downturnsForecast Cut & Stock Portfolio Risk Control - newser.com
Tools to monitor Charles River Laboratories International Inc. recovery probabilityQuarterly Portfolio Review & High Conviction Trade Alerts - newser.com
Applying chart zones and confluence areas to Charles River Laboratories International Inc.Market Sentiment Report & Consistent Income Trade Recommendations - newser.com
How Charles River Laboratories International Inc. stock moves on employment dataQuarterly Profit Report & Expert Approved Momentum Ideas - newser.com
Cooke & Bieler LP Increases Stock Position in Charles River Laboratories International, Inc. $CRL - MarketBeat
Sumitomo Mitsui Trust Group Inc. Acquires 2,340 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
Bessemer Group Inc. Cuts Stock Position in Charles River Laboratories International, Inc. $CRL - MarketBeat
Charles River Laboratories (CRL): Exploring Valuation After New Drug Discovery Collaborations Boost Innovation Prospects - simplywall.st
UNIVEST FINANCIAL Corp Trims Stake in Charles River Laboratories International, Inc. $CRL - MarketBeat
How Recent Moves Are Rewriting the Story for Charles River Laboratories - Yahoo Finance
AlphaQuest LLC Invests $368,000 in Charles River Laboratories International, Inc. $CRL - MarketBeat
What to Expect From Charles River Laboratories' Q3 2025 Earnings Report - MSN
Why Charles River Laboratories International Inc. (RV6) stock is upgraded to buyEarnings Overview Summary & Real-Time Market Sentiment Reports - newser.com
How to integrate Charles River Laboratories International Inc. into portfolio analysis tools - newser.com
Does Charles River Laboratories International Inc. (RV6) stock trade below intrinsic valueWeekly Loss Report & Weekly Watchlist of Top Performers - newser.com
Will Charles River Laboratories International Inc. stock keep outperforming rivals2025 Market Outlook & Safe Capital Growth Tips - newser.com
What to do if you’re stuck in Charles River Laboratories International Inc.2025 Bull vs Bear & Precise Swing Trade Entry Alerts - newser.com
Using Ichimoku Cloud for Charles River Laboratories International Inc. technicalsPortfolio Risk Summary & Daily Volume Surge Signals - newser.com
Charles River Laboratories International Inc Stock (CRL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.64%
1.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):